PureTech Health News
Press releases
Press releases 2018-06-19
Karuna
PureTech’s Karuna Receives $8 Million Wellcome Trust Award to Advance Phase 2 Product Candidate for the Treatment of Schizophrenia
Continue
Press releases 2018-06-05
Gelesis
PureTech’s Gelesis Appoints Harry Leider, former Walgreens Chief Medical Officer, as Chief Medical Officer and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, to Board of Directors

Appointments bring strong track records of leadership and experience in commercial launches and medical affairs

PureTech Health plc (LSE: PRTC) ("PureTech Health"), an advanced, clinical-stage biopharmaceutical company, announced today that its affiliate, Gelesis, has appointed Harry Leider, MD, MBA, former Chief Medical Officer and Group Vice President of Walgreens, as Chief Medical Officer. Gelesis also announced the appointment of Paul Fonteyne, Chairman and former CEO of Boehringer Ingelheim USA, to the Board of Directors.

Continue
Press releases 2018-05-30
PureTech Health to Present at Jefferies 2018 Global Healthcare Conference

PureTech Health plc (LSE: PRTC) ("PureTech Health"), an advanced, clinical-stage biopharmaceutical company, announced today that Joep Muijrers, PhD, Chief Financial Officer at PureTech Health, will present at the Jefferies 2018 Global Healthcare Conference in New York City on Wednesday, 6 June, at 9:30AM EDT.

Continue
Press releases 2018-05-22
Alivio
PureTech’s Alivio Granted Two US Patents Broadly Covering Compositions of Matter for Inflammation-Targeting Technology Platform

PureTech Health plc (LSE: PRTC) ("PureTech Health"), an advanced, clinical-stage biopharmaceutical company, announced today that its affiliate, Alivio Therapeutics, has been granted two key patents broadly covering its inflammation-targeting technology platform. 

Continue
Press releases 2018-05-18
Results of Annual General Meeting

The Annual General Meeting of PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), was held at 3.00 pm BST on Friday 18 May 2018. All of the resolutions proposed at the Annual General Meeting were duly passed by the shareholders on a poll. 

CONTINUE

Press releases 2018-05-09
Akili
PureTech’s Akili Raises $55 Million to Advance Digital Medicine Platform and Product Pipeline Aimed at Treating Cognitive Dysfunction

Proceeds will advance commercial and clinical stage pipeline in ADHD, multiple sclerosis, and depression

PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, announced today that its affiliate, Akili Interactive (“Akili”), has successfully completed a $55 million financing round. This financing was led by Temasek and included both new and existing strategic and institutional investors Baillie Gifford, Amgen Ventures, M Ventures (the CVC fund of Merck KGaA, Darmstadt, Germany), Jazz Venture Partners, Canepa Advanced Healthcare Funds, and Brooklands Capital Strategies.

Continue
Press releases 2018-05-02
Sonde
PureTech Health Affiliate Sonde Adds Thai Lee to Board of Directors

Appointment brings extensive business growth experience to affiliate’s Board of Directors

PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, is pleased to note that Sonde Health, an affiliate of PureTech Health, today announced the appointment of Thai Lee to its Board of Directors. Ms Lee is recognised as a prominent business leader in the information technology industry and brings more than two decades of experience to Sonde’s Board of Directors.

Continue
Press releases 2018-04-24
PureTech Health Appoints Joep Muijrers as Chief Financial Officer

Life sciences veteran brings strong track record of portfolio management, M&A, partnerships, IPOs, equity financings, and capital finance

PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, is pleased to announce today the appointment of Joep Muijrers, as the Company’s Chief Financial Officer after 11 successful years as a Partner and Portfolio Manager at LSP (Life Sciences Partners), a trans-Atlantic investor group with exclusive focus on life sciences, where he helped several companies become leaders in the biopharma industry and generated tremendous value for his firm’s stakeholders.

Continue
Press releases 2018-04-16
PureTech Health Announces Annual Results for Year Ended 31 December 2017
Press releases 2018-04-10
PureTech Health Affiliates Expand Digital Medicine IP Portfolios with Key Patent Issuances

US and international patent grants for Akili and Sonde technology platforms highlight PureTech’s foundational leadership position in the growing field of digital medicine

PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced, clinical-stage biopharmaceutical company, announced today that its affiliates, Akili Interactive Labs, Inc. and Sonde Health, Inc., have been granted key patents broadly covering their respective proprietary technology platforms.

Continue

@PureTechH